3,4-methylenedioxymethamphetamine (ecstasy) inhibits dyskinesia expression and normalizes motor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates. [electronic resource]
Producer: 20031104Description: 9107-15 p. digitalISSN:- 1529-2401
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
- Animals
- Antiparkinson Agents -- adverse effects
- Behavior, Animal -- drug effects
- Callithrix
- Disease Models, Animal
- Dopamine Agonists -- pharmacology
- Dose-Response Relationship, Drug
- Dyskinesia, Drug-Induced -- etiology
- Female
- Levodopa -- adverse effects
- Male
- Motor Activity -- drug effects
- N-Methyl-3,4-methylenedioxyamphetamine -- therapeutic use
- Parkinsonian Disorders -- chemically induced
- Receptor, Serotonin, 5-HT1B
- Receptors, Serotonin -- drug effects
- Receptors, Serotonin, 5-HT1
- Serotonin Antagonists -- pharmacology
- Serotonin Receptor Agonists -- pharmacology
- Selective Serotonin Reuptake Inhibitors -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.